• 1. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 2. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 3. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 4. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 5. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Comprehensive Analysis of Cyclobutanecarboxylic acid, 2-(aminomethyl)-, (1S,2R)- (CAS No. 496877-66-8)

Cyclobutanecarboxylic acid, 2-(aminomethyl)-, (1S,2R)- (CAS No. 496877-66-8) is a chiral cyclobutane derivative that has garnered significant attention in pharmaceutical and organic chemistry research. This compound, characterized by its unique stereochemistry and functional groups, serves as a critical building block in the synthesis of bioactive molecules. Its aminomethyl and carboxylic acid moieties make it a versatile intermediate for drug discovery, particularly in the development of small-molecule therapeutics targeting neurological and metabolic disorders.

Recent trends in AI-driven drug discovery and green chemistry have amplified interest in compounds like Cyclobutanecarboxylic acid, 2-(aminomethyl)-, (1S,2R)-. Researchers are exploring its potential in enantioselective synthesis, a hot topic in asymmetric catalysis. The compound's rigid cyclobutane ring structure also aligns with the growing demand for conformationally constrained scaffolds in medicinal chemistry, which improve drug selectivity and reduce off-target effects.

The stereospecificity of (1S,2R)- configuration is another focal point, as it influences the compound's pharmacokinetic properties. Studies suggest that this stereoisomer may exhibit enhanced metabolic stability compared to its counterparts, a feature highly sought after in preclinical drug development. Additionally, its hydrogen-bonding capacity makes it a candidate for designing protein-ligand interactions, a key area in computational chemistry and molecular docking simulations.

From an industrial perspective, CAS No. 496877-66-8 is often discussed in the context of scalable synthesis and cost-effective production. Innovations in continuous flow chemistry and biocatalysis have enabled more efficient routes to its manufacture, addressing challenges like racemization and yield optimization. These advancements align with the pharmaceutical industry's push toward sustainable manufacturing practices.

In summary, Cyclobutanecarboxylic acid, 2-(aminomethyl)-, (1S,2R)- represents a convergence of structural novelty and practical utility. Its applications span drug design, material science, and catalysis, making it a compound of enduring relevance in both academic and industrial settings. As research continues to uncover its potential, this molecule is poised to play a pivotal role in addressing unmet medical needs and advancing synthetic methodologies.

• 215597-45-8(2-(aminomethyl)cyclopropanecarboxylic acid)
• 701-54-2(4-(Aminomethyl)cyclohexanecarboxylic Acid)
• 1197-18-8(Tranexamic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)